Abstract
Atopic dermatitis (AD) is a common chronic inflammatory skin condition which impacts psychological wellbeing and social relationships. There have been studies of AD’s impact on quality of life (QoL) in Western countries, but these findings cannot be directly extrapolated to Asian populations with genetic, environmental and cultural differences. Therefore, we aimed to systematically review the literature pertaining to QoL impairment in AD in East and Southeast Asia to characterize the impact of AD on patients and their families, and to identify the factors affecting the degree of QoL impairment. A search of English language papers was conducted on MEDLINE, EMBASE, PSYCInfo, Global Health and Web of Science. Observational studies measuring QoL using single or multi-item instruments in people with self-reported or physician diagnosed atopic dermatitis were included. 27 studies from 29 articles were included and synthesized. There is data documenting QoL impairment in AD sufferers and their families, across a wide range of Asian countries, healthcare settings and ages. Aspects of QoL impacted to a greater extent included symptoms of itch, feelings of embarrassment, and sleep disturbance. Severity of disease affects the degree of impairment of QoL, but there is no apparent link between QoL impairment and patient demographic factors, or other medical factors such as age at diagnosis or duration of illness. Our findings also highlighted the need for clinicians to actively explore the impact of patient’s symptoms, especially in an Asian context where healthcare communications are traditionally doctor-centric.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Atopic dermatitis (AD) is a common type of chronic inflammatory skin condition, with a particular subtype associated with a heightened immune response to common allergens [1]. It is characterized by itchy lesions most commonly on the flexural surfaces and affects mainly children.
Quality of life (QoL) is a multidimensional construct encompassing one’s mental, physical and social wellbeing. While non-life threatening, atopic dermatitis is associated with QoL impairment; the itching may affect mood and sleep hygiene, and the lesions may cause embarrassment, thus impacting on psychological wellbeing and social relationships [1]. The wellbeing of carers may also be affected, as they often must modify their lifestyle to provide care. In view of its importance, QoL has been included as one of the four core outcome domains to ideally be measured in all atopic dermatitis clinical trials [2]. While QoL of AD patients has been widely studied in Western countries [3,4,5], these findings cannot automatically be extrapolated to the Asian context as genetic, environmental and cultural factors may affect clinical manifestation and prevalence of AD between races [6, 7]. It is has been reported that filaggrin null mutations which vary between people of different ethnicities may be positively correlated with the severity of AD [8]. For example, the Filaggrin null mutation c.3321delA is not found in western populations but has been reported in East Asian populations such as Japan, China, Korea, Taiwan and Singapore [6]. Differences in the cultural context may also lead to differences in individual’s perception of their disease. In addition the greater involvement of family with the Confucian principle of family-centered care giving [9], may impact on family QoL.
With these differences, it was pertinent to summarize what is known about the impact of AD specifically in the Asian context. Hence, this systematic review aimed to qualitatively synthesize and critique the published literature with two research questions in mind. First, does atopic dermatitis impact QoL in Asian countries, and if so, how and to what extent? Second, what are the determinants of QoL in atopic dermatitis among the Asian population?
Methods
The protocol was first developed using the PRISMA Statement [10] as a guideline. Details of the protocol were registered on PROSPERO and can be accessed at http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018106613.
A search strategy was developed with MeSH headings and keywords relevant to the population (people with atopic dermatitis), study design (observational studies), context (people from Asian countries), and outcome (QoL). The search for relevant studies was conducted in Aug 2018 on electronic databases MEDLINE, EMBASE, PSYCInfo, Global Health, and Web of Science (from inception to 21 Aug 2018).
The review process was conducted independently by two of our authors (Huang and Choo). Titles and abstracts of studies were retrieved and screened for their relevance to the research question using the inclusion/exclusion criteria in Table 1. Potentially eligible articles were then accessed, and their full text assessed for eligibility. Full-text articles failing to fulfil the selection criteria were excluded and the reasons documented.
Data extraction were then conducted on full text articles which were eligible, using a pre-piloted form. Data extracted included general information, sample characteristics, study methodology, outcome measurements, and any other significant results or factors not in our pre-determined categories. The form was continuously reviewed and modified to reflect more accurately the information included in studies.
Data analysis
A qualitative synthesis of the findings was carried out and reported as a narrative summary.
Additional analysis was conducted on the Children’s Dermatology Life Quality Index (CDLQI) and Dermatology Life Quality Index (DLQI) scores. The CDLQI and DLQI scores were interpreted using validated severity stratifications by Waters et al. [11] and Hongbo et al. [12], respectively, to determine the degree of QoL impairment. Scores for each question in these questionnaires were grouped under six headings, and an aggregate score for each heading was calculated as according to the CDLQI and DLQI instructions for detailed analysis. The aspects of QoL with the three highest scores from each study were then highlighted to identify trends.
Risk of bias assessment
Included studies were assessed by both reviewers for risk of selection bias and information bias using an adapted tool (Appendix) based on Dodoo-Schittko et al. [13], and modified from the Newcastle–Ottawa Scale.
Results
The search yielded 4396 articles after removal of the duplicates. After screening and assessing full text for eligibility, 27 studies from 29 articles were included, as outlined in the PRISMA flow diagram (Fig. 1). The extracted data from the included studies are represented below (Table 2). Of the 27 studies, the countries represented included Singapore (four studies), Malaysia (two studies), Japan (five studies), Korea (six studies), Hong Kong (nine studies) and Taiwan (one study). Most studies were performed on patients under specialist care (dermatology clinics or hospitals), only one study was conducted in a primary care setting [14]. Four studies were population surveys using self-reported diagnoses to identify people with AD [15,16,17,18,19]. Nine QoL instruments were used, with the most used being Infant Dermatitis Quality of Life Index (four studies), CDLQI (15 studies), DLQI (six studies), Short form Health survey (four studies) and Euro-QoL-5 Dimension Index (three studies).
QoL impairment in people with atopic dermatitis
QoL was impaired in Asian people with AD. Mean IDQoL scores ranged from 6.8 to 7.7, but there is no validated interpretation for the absolute value of IDQoL [20]. CDLQI and DLQI scores ranged for 4.8–15.2 and 4.8–12.0, respectively, with most studies describing a “moderate” or “very large effect” on QoL as according to the interpretation by Waters et al. [11] and Hongbo et al. [12].
The Short Form Health Survey indicated that AD patients have a statistically significant QoL impairment in both Physical Component Scores (PCS) and Mental Component Scores (MCS) compared to healthy controls (HCs) [15, 21], except for one study [22] which showed only impairment in MCS and not PCS. Impairment of QoL was also statistically significant in AD patients compared to healthy controls in two studies using the EQ5D scale [16, 18, 19], with one study [23] reporting a 30–35% decrease in QoL by AD. Some studies showed a statistically significant QoL impairment in AD patients using Skindex-16 [24] or WHOQoL-26 [25].
Aspects of QoL affected are in the domains of symptoms and feelings, and sleep
The aspects of QoL affected were specified numerically in only four studies using CDLQI and four studies using DLQI (Table 3), while other studies using these QoL instruments only described the various aspects of QoL affected qualitatively. Symptoms of itch and feelings of embarrassment were the most pertinent aspects of QoL. Furthermore, sleep appeared to be an important aspect of QoL [22, 26,27,28,29], though one study [18, 19] showed no difference in sleep duration between AD patients and healthy controls. The findings from the analysis of CDLQI and DLQI was corroborated by Higaki et al. [24], which found that “symptoms” and “feelings” were more impacted than “functioning”. One study [30] using Short Form (SF)-36 and one [18, 19] using EQ5D also showed similar results, with statistically significant impact in aspects of QoL such as symptoms of “pain” and “discomfort”, and mental wellbeing.
QoL impairment in family members of people with AD
AD also impacts the QoL of family members. The Dermatitis Family Impact (DFI) scores ranged from 4.8 to 9.4 [21, 28, 29, 31]. Applying the interpretation proposed by Ricci et al. [3], three studies [21, 28, 29, 32] showed a minor impact, while one study [31] showed no impact in QoL.
In particular, the aspects most affected were family diet [28, 29, 32] and emotional wellbeing [21, 32]. Limitations to social and personal activities [21], sleep loss [32] and expenditure [28, 29] also were documented.
Determinants of QoL in people with AD
Of the 15 studies investigating the relationship between severity and QoL in AD, 14 showed a statistically significant correlation between severity and QoL impairment [14, 21,22,23,24, 26,27,28,29, 31,32,33,34,35,36,37]. Only one study observed that moderate/severe had similar levels of QoL impairment to mild AD patients [15]. However, this study acknowledged that their sample size was small and may have had insufficient power. Furthermore, their assessment of severity was self-rated, and had a different severity distribution from a previous study where severity of a similar sample population was measured based on clinical examination [38].
Beyond severity, there were no other clear links between general QoL impairment and patient demographics, such as age and gender, nor other medical factors, such as presence of concomitant atopic conditions, age at diagnosis, duration of illness and family history of atopy. However, a few studies found correlations between QoL and biological measurements, such as skin hydration [35, 36], trans-epidermal water loss [36] and several biomarkers [39]. Parent negativity [31, 40] was also shown to be associated with a lower QoL. Lastly, steroid phobia, whether from patients [25] or parents [36] was linked to a decreased QoL of AD patients.
Discussion
QoL was impaired in people with atopic dermatitis in Asian countries with average CDLQI and DLQI scores ranging from 4.8 to 15.2 (CDLQI mean of means = 9.1) and 4.8–12.0 (DLQI mean of means = 9.1) respectively, similar to other studies in Denmark (CDLQI = 8, DLQI = 5) [4] and the United States (CDLQI = 5.8, DLQI = 6.6) [5]. A review article also quoted that DLQI values of AD patients ranged from 4.5 to 21.4, with the mean of means being 12.2 [41]. While sociocultural differences between these populations may provide some answers as to differences in QoL impairment between countries, it would be hasty to draw major generalizations regarding specific differences between Asian and non-Asian populations, due to the lack of a head to head comparison between the various aspects of QoL affected in these two populations. Different cultures also vary in the way they interpret questionnaires [42], limiting the comparability between countries even with the same QoL instrument.
Aspects of QoL affected were in the domains of symptoms and feelings. In our analysis of the CDLQI, we also found that sleep was particularly affected among children. Indeed AD, like many inflammatory skin conditions such as psoriasis and urticaria, is known to be a highly pruritic disease [43]. This pruritus is enhanced at night, when trans-epidermal water loss (TEWL) in AD patients is greatest [44], affecting sleep quality through nocturnal awakenings [45]. Thus, clinicians should ensure that these aspects are adequately addressed in the care of their patients.
The nocturnal awakenings by AD patients also disrupted sleep for parents who often engage in co-sleeping (sleeping in the same bed) [46], or when they had to get up to attend to the child, leading to parents having their sleep reduced by a median of 45 and 39 min/night, respectively [47], consequently impacting family QoL.
There is a clear relationship between severity and degree of QoL impairment. The SCORAD and NESS used in included studies have subjective symptoms like itch as a category in its own right [48]. Itching also affected sleep quality and consequently QoL. Erythema was a feature in SCORAD and EASI [48], and a higher amount of erythema could be linked to greater impact in physical appearance and consequently social embarrassment.
Besides severity, there was no clear link between general QoL impairment and other medical or demographic factors. However, there were only a few studies investigating the effect of each factor on the QoL of AD patients. Therefore, it may be premature to conclude that these factors do not affect QoL. There were also other variables, such as “involvement of visible areas of the body”, that have been reported to be determinants of QoL impairment in AD, but were not investigated in the studies we identified.
Our findings highlight the need for clinicians to actively explore the impact of patient’s symptoms on QoL and consider using self-reported QoL questionnaires in their routine monitoring AD patients. This refinement of practice is especially important in the Asian context where patient-doctor communications are traditionally doctor-centered [9, 49], with a focus on symptomatology rather than socio-emotional matters [50].
A limitation of this review is that countries included in this study were not entirely representative of SEA and East Asia; there was a lack of papers from China due to our literature search being confined to English language papers and because of resource constraints not using any Chinese bibliographic databases. Studies from developing countries in Asia were few, and it would be inappropriate to generalize the findings from developed counterparts given the differences in health care, illness behaviors and psychosocial characteristics. There remains a need for research to explore the impact of AD on QoL in these other countries.
Furthermore, many papers were unclear about the study’s inclusion and exclusion criteria, rendering it difficult to assess selection bias (Table 4). Studies should also be transparent about their sampling methods.
The studies included had many differences in their methods, whether in terms of diagnosis or severity scoring or outcome measures. This made comparisons between studies difficult. The interpretation by Ricci et al. [3] was not validated, which may affect the interpretation of DFI scores. Future research should be geared towards the validation of outcome measures and their interpretations and forming a consensus on the instruments used to measure QoL of AD patients.
Conclusion
QoL is impaired for both Asian AD sufferers and their family. Sufferers are most affected by the itch, sleep disturbance and embarrassment associated with AD. Severity of disease affects the degree of impairment of QoL on AD patients. Greater attention needs to be given to validation of instruments and consistency of their use, and future research should extend to the investigation of QoL on AD patients in other developing countries in Asia.
Abbreviations
- AD:
-
Atopic dermatitis
- QoL:
-
Quality of life
- HC:
-
Healthy controls
- CDLQI:
-
Children’s Dermatology Life Quality Index
- DLQI:
-
Dermatology Life Quality Index
- PCS:
-
Physical Component Scores
- MCS:
-
Mental Component Scores
- DFI:
-
Dermatitis Family Impact
- POEM:
-
Patient-Oriented Eczema Measure
- NESS:
-
Nottingham Eczema Severity Score
- SCORAD:
-
SCORing Atopic Dermatitis
- SD:
-
Standard deviation
- NR:
-
Not reported
- SF:
-
Short Form
- yo:
-
Years-old
References
Weidinger S, Novak N (2016) Atopic dermatitis. Lancet 387(10023):1109–1122
Schmitt J, Spuls P, Boers M et al (2012) Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy 67(9):1111–1117
Ricci G, Bendandi B, Bellini F et al (2007) Atopic dermatitis: quality of life of young Italian children and their families and correlation with severity score. Pediatr Allergy Immunol 18(3):245–249
Holm EA, Wulf HC, Stegmann H et al (2006) Life quality assessment among patients with atopic eczema. Br J Dermatol 154(4):719–725
Kiebert G, Sorensen SV, Revicki D et al (2002) Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 41(3):151–158
Torrelo A (2014) Atopic dermatitis in different skin types. What is to know? J Eur Acad Dermatol Venereol 28:2–4
Levy RM, Gelfand JM, Yan AC (2003) The epidemiology of atopic dermatitis. Clin Dermatol 21(2):109–115
Chen H, Common J, Haines R et al (2011) Wide spectrum of filaggrin-null mutations in atopic dermatitis highlights differences between Singaporean Chinese and European populations. Br J Dermatol 165(1):106–114
Matusitz J, Spear J (2015) Doctor-patient communication styles: a comparison between the United States and three Asian countries. J Hum Behav Soc Environ 25(8):871–884
Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269
Waters A, Sandhu D, Beattie P et al (2010) Severity stratification of Children’s Dermatology Life Quality Index (CDLQI) scores: pa-8. Br J Dermatol 163:121
Hongbo Y, Thomas CL, Harrison MA et al (2005) Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Investig Dermatol 125(4):659–664
Dodoo-Schittko F, Brandstetter S, Blecha S et al (2017) Determinants of quality of life and return to work following acute respiratory distress syndrome: a systematic review. Dtsch Arztebl Int 114(7):103
Chuh AAT, Chan HHL (2005) Effect on quality of life in patients with pityriasis rosea: is it associated with rash severity? Int J Dermatol 44(5):372–377
Arima K, Gupta S, Gadkari A et al (2018) Burden of atopic dermatitis in Japanese adults: analysis of data from the 2013 national health and wellness survey. J Dermatol 45(4):390–396
Cheok S, Yee F, Ma JYS et al (2018) Prevalence and descriptive epidemiology of atopic dermatitis and its impact on quality of life in Singapore. Br J Dermatol 178(1):276–277
Itakura A, Tani Y, Kaneko N et al (2018) Impact of chronic urticaria on quality of life and work in Japan: results of a real-world study. J Dermatol 45(8):963–970
Kwak Y, Kim Y (2017) Health-related quality of life and mental health of adults with atopic dermatitis. Arch Psychiatr Nurs 31(5):516–521
Lee SH, Lee SH, Lee SY et al (2018) Psychological health status and health-related quality of life in adults with atopic dermatitis: a nationwide cross-sectional study in South Korea. Acta Derm Venereol 98(1):89–97
Basra M, Gada V, Ungaro S et al (2013) Infants’ Dermatitis Quality of Life Index: a decade of experience of validation and clinical application. Br J Dermatol 169(4):760–768
Ho RCM, Giam YC, Ng TP et al (2010) The influence of childhood atopic dermatitis on health of mothers, and its impact on Asian families. Pediatr Allergy Immunol 21(3):501–507
Lam KM (2010) Quality of life assessment among patients with atopic eczema attending dermatology clinics in Hong Kong. Hong Kong J Dermatol Venereol 18(4):181–188
Kim C, Park KY, Ahn S et al (2015) Economic impact of atopic dermatitis in Korean patients. Ann Dermatol 27(3):298–305
Higaki Y, Kawamoto K, Kamo T et al (2004) Measurement of the impact of atopic dermatitis on patients’ quality of life: a cross-sectional and longitudinal questionnaire study using the Japanese version of Skindex-16. J Dermatol 31(12):977–982
Kawashima M, QOL Research Forum for Patients with Atopic Dermatitis (2006) Quality of life in patients with atopic dermatitis: impact of tacrolimus ointment. Int J Dermatol 45(6):731–736
Kim DH, Li K, Seo SJ et al (2012) Quality of life and disease severity are correlated in patients with atopic dermatitis. J Korean Med Sci 27(11):1327–1332
Ng MSY, Tan S, Chan NHQ et al (2018) Effect of atopic dermatitis on quality of life and its psychosocial impact in Asian adolescents. Australas J Dermatol 59(2):E114–E117
Ghani AAA, Noor NM, Muhamad R et al (2012) Quality of life and its associated factors among children with atopic eczema in Kelantan, Malaysia. Int J Collab Res Intern Med Public Health 4(11):1816–1827
Ghani AAA, Noor NM, Muhamad R et al (2013) Atopic eczema in children: disease severity, quality of life and its impact on family. Int Med J 20(3):320–322
Chen YC, Wu CS, Lu YW et al (2013) Atopic dermatitis and non-atopic hand eczema have similar negative impacts on quality of life: implications for clinical significance. Acta Derm Venereol 93(6):749–750
Jang HJ, Hwang S, Ahn Y et al (2016) Family quality of life among families of children with atopic dermatitis. Asia Pac Allergy 6(4):213–219
Aziah MS, Rosnah T, Mardziah A et al (2002) Childhood atopic dermatitis: a measurement of quality of life and family impact. Med J Malaysia 57(3):329–339
Ang SB, Teng CWC, Monika TP et al (2014) Impact of atopic dermatitis on health-related quality of life among infants and children in Singapore: a pilot cross-sectional study. Proc Singap Healthc 23(2):100–107
Hon KL, Kung J, Leung T (2018) Evaluating skin equipment for assessing childhood eczema. Australas J Dermatol 59(Supplement 1):18
Hon KL, Kung JSC, Tsang KYC et al (2018) Do we need another symptom score for childhood eczema? J Dermatol Treat 29(5):510–514
Hon KL, Tsang YCK, Pong NH et al (2015) Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema. J Dermatol Treat 26(5):418–425
Yano C, Saeki H, Ishiji T et al (2013) Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis. J Dermatol 40(9):736–739
Saeki H, Tsunemi Y, Fujita H et al (2006) Prevalence of atopic dermatitis determined by clinical examination in Japanese adults. J Dermatol 33(11):817–819
Hon KLE, Ching GKW, Wong KY et al (2008) A pilot study to explore the usefulness of antibody array in childhood atopic dermatitis. J Natl Med Assoc 100(5):500–504
Oh SH, Bae BG, Park CO et al (2010) Association of stress with symptoms of atopic dermatitis. Acta Derm Venereol 90(6):582–588
Lewis V, Finlay AY (2004) 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc 9:169–180
Lynn P, Japec L, Lyberg L (eds) (2006) What’s so special about cross-national surveys? International workshop on comparative survey design and implementation (CSDI). DEU
Gupta MA, Gupta AK, Schork NJ et al (1994) Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 56(1):36–40
Lavery MJ, Stull C, Kinney MO et al (2016) Nocturnal pruritus: the battle for a peaceful night’s sleep. Int J Mol Sci 17(3):425
Gowda S, Goldblum OM, McCall WV et al (2010) Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol 63(1):114–123
Chamlin SL, Mattson CL, Frieden IJ et al (2005) The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis. Arch Pediatr Adolesc Med 159(8):745–750
Moore K, David TJ, Murray CS et al (2006) Effect of childhood eczema and asthma on parental sleep and well-being: a prospective comparative study. Br J Dermatol 154(3):514–518
Rehal B, Armstrong A (2011) Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985–2010. PLoS ONE 6(4):e17520
Pun JK, Chan EA, Wang S et al (2018) Health professional-patient communication practices in East Asia: an integrative review of an emerging field of research and practice in Hong Kong, South Korea, Japan, Taiwan, and Mainland China. Patient Educ Couns 101(7):1193–1206
Claramita M, Van Dalen J, Van Der Vleuten CP (2011) Doctors in a Southeast Asian country communicate sub-optimally regardless of patients’ educational background. Patient Educ Couns 85(3):e169–e174
Molloy JD, Clarke A, Morris J, Lim R, Ben-Shoshan M (2019) Abstracts PDS. Allergy 74(S106):130–331
Bae JM, Ha B, Lee H et al (2012) Prevalence of common skin diseases and their associated factors among military personnel in Korea: a cross-sectional study. J Korean Med Sci 27(10):1248–1254
Hon KLE, Leung TF, Wong KY et al (2008) Does age or gender influence quality of life in children with atopic dermatitis? Clin Exp Dermatol 33(6):705–709
Hon KL, Pong NH, Poon TCW et al (2014) Quality of life and psychosocial issues are important outcome measures in eczema treatment. J Dermatol Treat 26(1):83–89
Hon KL, Tsang YC, Poon TC et al (2016) Dairy and nondairy beverage consumption for childhood atopic eczema: what health advice to give? Clin Exp Dermatol 41(2):129–137
Acknowledgements
The authors would like to thank their colleagues for their valuable input. This research has been previously presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2019 [51].
Funding
Open Access funding enabled and organized by Projekt DEAL. The authors received no specific funding for this work.
Author information
Authors and Affiliations
Contributions
JH, HES, and CA contributed in the study’s conception and design. JH and YJC reviewed the studies independently. All authors contributed to the interpretation of results and drafting of manuscript. All authors approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Huang J, Choo YJ, and Smith HE declare no potential conflict of interests. Christian Apfelbacher is a member of the executive committee of the Harmonizing Outcomes Measures for Eczema (HOME) initiative and lead of the quality of life working group within HOME. He has received honorariums and institutional funding from Dr Wolff GmbH, and honorariums from Sanofi Genzyme.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix: instrument in assessing risk of selection and information bias of studies
Appendix: instrument in assessing risk of selection and information bias of studies
Selection bias
Description of study population
Inclusion and exclusion criteria should be adequately specific. They should include:
-
1. Clear definition of atopic dermatitis: papers should state if they used a criteria for diagnosis (e.g. UK Working Party criteria), patient diagnosis or if atopic dermatitis was self reported.
-
2. Demographics of study population: There should be further inclusion and exclusion criteria on the demographics (e.g. Age) of study population.
-
3. Setting: Studies should mention the setting in which people with atopic dermatitis were obtained (whether clinical or population based samples).
Categories:
-
Clear: All three components (diagnosis, demographics and setting) were specified.
-
Unclear: two components were specified.
-
No inclusion and/or exclusion criteria: Only one or no component was specified.
Sampling method
This category assesses if the method of sampling from the study population (as specified by diagnosis, demographics and setting) was truly random and without bias.
Categories:
-
Random: the sample was drawn randomly from study population/study specified or that there was complete enumeration from study population.
-
Not random: the sample was not drawn randomly. This includes choosing patients based on convenience or any other extrinsic factor.
-
Unclear: study did not state how the sample was drawn from study population.
Information bias
Classification of exposure
The exposure in this instance refers to the diagnosis of atopic dermatitis. The method in which the diagnosis of atopic dermatitis was established was assessed.
Categories:
-
Secure records: study should specify that diagnoses were made by physician or from secured medical records. Physician diagnoses can be established through the use of diagnostic criteria or clinical judgment.
-
Self reported: diagnoses of atopic dermatitis were reported by participants of the study, with no verification with secured records.
-
Unclear: study did not state how atopic dermatitis was established.
Classification of outcomes
The outcome in this instance refers to quality of life (QoL) of the study sample. The method of measuring QoL was assessed.
Categories.
-
Validated psychometric instruments: instruments which have been evaluated to have adequate validity and reliability.
-
Non-validated psychometric instruments: instruments which have not been shown to have adequate validity and reliability. This includes translation of validated psychometric instruments which in themselves have not been validated.
-
Self-reported QoL: studies in which QoL was asked directly and self-reported.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Huang, J., Choo, Y.J., Smith, H.E. et al. Quality of life in atopic dermatitis in Asian countries: a systematic review. Arch Dermatol Res 314, 445–462 (2022). https://doi.org/10.1007/s00403-021-02246-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-021-02246-7